Int'l Insights: Bullish Stocks
Buying Japanese Drug Store Names: Welcia (3141-JP) and Sundrug (9989-JP)Below we lay out what we believe is a compelling case to add exposure to two Japanese drug store stocks at current levels.
Japan Remains Leadership. Likely owing to easy monetary policy from the Bank of Japan and the lowest inflation rate of all major economies, Japanese market indexes including the TOPIX, Nikkei 225, and TOPIX Small remain in 7+ month RS uptrends -- remain overweight. Japan has been a favorite country since late-March, and we have continued to see improvement ever since.
Consumer Staples is Leadership Within Japan. Global Consumer Staples stocks have had mixed results, but that is not the case within Japan. Of Vermilion's twelve Japanese Sectors, Consumer Staples holds the best relative strength ranking (RSR).
Int'l Group CS-35 Drug Stores, Japan. Vermilion's international Group CS-35 Drug Stores, Japan displays bullish price and RS downtrend reversals... see chart below. When the majority of s
Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.
Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.